InMode to Participate at the UBS Healthcare One-on-One Virtual Day
InMode Ltd. (Nasdaq: INMD), a prominent global provider of innovative medical technologies, announced participation in the UBS Healthcare One-on-One Virtual Day on June 1, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
InMode Ltd. (Nasdaq: INMD), a prominent global provider of innovative medical technologies, announced participation in the UBS Healthcare One-on-One Virtual Day on June 1, 2022. CEO Moshe Mizrahy and CFO Yair Malca will represent the company. Interested parties can schedule meetings through their UBS representative or by contacting Miri Segal at msegal@ms-ir.com. InMode specializes in medical devices using radiofrequency technology, serving various medical fields including plastic surgery and dermatology.
Details
News Market Reaction – INMD
The recorded move for INMD in the trading session of this news was +0.43%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
YOKNEAM, Israel, May 23, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial Officer, will participate at the UBS Healthcare One-on-One Virtual Day on June 1st, 2022. To schedule a meeting, please contact your UBS representative or Miri Segal at msegal@ms-ir.com.
For more information about the event, visit InMode's investor relations site here.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
917-607-8654
Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/inmode-to-participate-at-the-ubs-healthcare-one-on-one-virtual-day-301552186.html
SOURCE InMode Ltd.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.